Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
KRAS and TP53 Circulating Tumor DNA are Prognostic in Localized Pancreatic Cancer.
Journal: Annals of surgical oncology
Published: January 12, 2026
Mutant KRAS in Circulating Tumor DNA as a Biomarker in Localized Pancreatic Cancer Patients Treated With Neoadjuvant Chemotherapy.
Journal: Annals of surgery
Published: October 29, 2024
Environmental and Genetic Risk Factors for Gastric Cancer.
Journal: Cancer treatment and research
Published: August 30, 2024
Prospective Evaluation of Circulating Tumor DNA Using Next-generation Sequencing as a Biomarker During Neoadjuvant Chemotherapy in Localized Pancreatic Cancer.
Journal: Annals of surgery
Published: January 23, 2024
Trametinib Potentiates Anti-PD-1 Efficacy in Tumors Established from Chemotherapy-Primed Pancreatic Cancer Cells.
Journal: Molecular cancer therapeutics
Published: November 29, 2023
Establishing the clinical relevance of grade A post-hepatectomy liver failure.
Journal: Journal of surgical oncology
Published: October 26, 2023
The inaccuracies of gastric adenocarcinoma clinical staging and its predictive factors.
Journal: Journal of surgical oncology
Published: February 23, 2023
Environmental and genetic risk factors for gastric cancer.
Journal: Journal of surgical oncology
Published: February 24, 2022
Caveat Emptor: 2-Year Follow-Up Evaluating Post-Resection Liver Decompensation in Patients with Underlying Cirrhosis and Incident Hepatocellular Carcinoma.
Journal: Annals of surgical oncology
Published: September 14, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026